Press Releases

Liquidia Closes Acquisition of RareGen

Merger   Reinforc es Company’s Commitment to Patients with PAH Paul Manning and Roger Jeffs Join Liquidia Corporation Board of Directors RESEARCH TRIANGLE PARK, N.C. , Nov. 18, 2020 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (NASDAQ: LQDA), a late-stage clinical biopharmaceutical company
Nov 18, 2020

Liquidia Announces Results of Special Meeting of Stockholders

Stockholders Approve RareGen Acquisition Merger Expected to Close on   or A bout November 18 , 2020 RESEARCH TRIANGLE PARK, N.C. , Nov. 16, 2020 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (NASDAQ: LQDA), a late-stage clinical biopharmaceutical company focused on the development and
Nov 16, 2020

Liquidia to Present at the 2020 Jefferies Virtual London Healthcare Conference

RESEARCH TRIANGLE PARK, N.C. , Nov. 12, 2020 (GLOBE NEWSWIRE) -- Liquidia Technologies , Inc. (Nasdaq: LQDA), a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products utilizing its proprietary PRINT® technology, today announced that Neal
Nov 12, 2020

Liquidia Announces Postponement of Special Meeting of Stockholders

RESEARCH TRIANGLE PARK, N.C. , Oct. 19, 2020 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (NASDAQ: LQDA), a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products using its proprietary PRINT ®  technology, today announced that it has
Oct 19, 2020
Displaying 21 - 30 of 98